6533b872fe1ef96bd12d2e96
RESEARCH PRODUCT
Immune oncology in hepatocellular carcinoma-hype and hope.
Marcus-alexander WörnsPeter R. Gallesubject
SorafenibOncologyNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularPyridinesMEDLINEAntineoplastic AgentsDrug resistance03 medical and health sciences0302 clinical medicineImmune systemInternal medicinemedicineCarcinomaNeoplasmHumans030212 general & internal medicineProtein Kinase Inhibitorsbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral MedicineSorafenibmedicine.diseaseDrug Resistance NeoplasmHepatocellular carcinoma030211 gastroenterology & hepatologybusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2017-03-14 | Lancet (London, England) |